The DOI matches its Crossref record; 76 of the 78 references it cites were found in a registry or an index.
Olanzapine therapy in anorexia nervosa: psychobiological effects
Open accessAbstract
Dopamine impairments occur in anorexia nervosa. The aim of this study was to see whether treatment with the atypical dopamine antagonist antipsychotic olanzapine improves the disorder. Thirty anorexics, 18 restricted and 12 bingeing-purging, underwent a 3-month course of cognitive behavioral therapy, plus at random and double-blinded oral olanzapine (2.5 mg for 1 month, 5 mg for 2 months) in half and oral placebo in the other half of them. BMI, psychopathological aspects (eating disorder inventory, Hamilton Rating Scale, Buss-Durkee Rating Scale, Yale Brown Cornell for Eating Disorders Rating Scale, temperament-character inventory), and homovanillic acid blood concentrations for dopamine secretion, were monitored at baseline and then monthly during the trial. At the end of the trial BMI, total eating disorder inventory, total Yale Brown Cornell for Eating Disorders Rating Scale, Buss-Durkee Rating Scale, Hamilton Rating Scale scores and in olanzapine-treated patients the subitems of eating disorder inventory ineffectiveness and maturity fear, of Buss-Durkee Rating Scale direct aggressiveness, of temperament-characteristic inventory persistence had improved significantly. When stratified for anorexia nervosa subtype, BMI changes were significant among anorexia nervosa bingeing-purging patient, 'depression' (Hamilton Rating Scale) and 'direct aggressiveness' (Buss-Durkee Rating Scale) among anorexia nervosa bingeing-purging patients, 'persistence' (temprerament-characteristic inventory), among anorexics restricted patients, with a trend toward significance for obsessivity-compulsivity (Yale Brown Cornell for Eating Disorders Rating Scale). homovanilic acid blood levels increased significantly in the cognitive behavioral therapy+olanzapine group. No correlations were observed between homovanilic acid concentrations and psychopathological parameters. The pharmacological treatment can significantly improve specific aspects of anorexia nervosa.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
An inventory for assessing different kinds of hostility.
Buss, A. H., & Durkee, A. (1957) · Journal of Consulting Psychology · doi:10.1037/h0046900 · Cited by 2,614
The temperament and character inventory (TCI) : a guide to its development and use
Cloninger, C. R. (1994) · Medical Entomology and Zoology · Cited by 2,319
Handbook of treatment for eating disorders
(1997) · Choice Reviews Online · doi:10.5860/choice.35-2151 · Cited by 1,074
Nyman‐Carlsson, E., & Garner, D. M. (2017) · Springer eBooks · doi:10.1007/978-981-287-104-6_192 · Cited by 595
Antipsychotic-induced weight gain: a review of the literature.
Allison, D. B., & Casey, D. E. (2001) · PubMed · Cited by 594
Strober, M. A., Freeman, R., Lampert, C., Diamond, J., & Kaye, W. H. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.393 · Cited by 557
Amisulpride, an Unusual “Atypical” Antipsychotic: A Meta-Analysis of Randomized Controlled Trials
Leucht, S., Pitschel‐Walz, G., Engel, R. R., & Kissling, W. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.2.180 · Cited by 470
Association of antipsychotic druginduced weight gain with a 5-HT2C receptor gene polymorphism
Reynolds, G. P., Zhang, Z., & Zhang, X. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08913-4 · Cited by 413
Research works printed but not linked: 13
- Allison, 2001, J Clin Psychiatry, 62, 22
- Backer, 2003, Biol Psychiatry, 53, 133S
- Bosanac, 2005, Aust N Z J Psychiatry, 37, 494
- Bymaster, 1997, J Clin Psychiatry, 58, 28
- Coates, 2000, Br J Psychiatry, 25, S92
- Gaskill, 2001, Int J Eat Disord Review, 12, 1
- Gillberg, 1983, Am J Psychiatry, 140, 948
- Halmi, 1977, Psychopharmacol Bull, 13, 63
- Klump, 2005, In J Eat Disord, 37, 541
- Lipkovich, 2004, Biol Psychiatry, 55, 181S
- Mangano, 2004, Ital J Psychopathology, 8, 249
- Odink, 1986, Bio Amines, 3, 257
- Owen, 1983, Psychopharmacol Bull, 19, 578
Cited by
Sorted by citations
Treasure, J. L., Claudino, A. M., & Zucker, N. L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61748-7 · Cited by 661
Identification and Management of Eating Disorders in Children and Adolescents
Rosen, D. S. (2010) · PEDIATRICS · doi:10.1542/peds.2010-2821 · Cited by 387
Watson, H. J., & Bulik, C. M. (2013) · Psychological Medicine · doi:10.1017/s0033291712002620 · Cited by 339
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299
Treasure, J. L., Zipfel, S., Micali, N., Wade, T. D., Stice, E. M., Claudino, A. M., Schmidt, U. H., Frank, G., Bulik, C. M., & Wentz, E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.74 · Cited by 302
Bissada, H., Tasca, G. A., Barber, A. M., & Bradwejn, J. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07121900 · Cited by 268
Murray, S. B., Quintana, D. S., Loeb, K. L., Griffiths, S., & Le Grange, D. (2019) · Psychological Medicine · doi:10.1017/s0033291718002088 · Cited by 258
Olanzapine versus placebo in adult outpatients with anorexia nervosa: a randomized clinical trial
Attia, E., Steinglass, J. E., Walsh, B. T., Wang, Y., Wu, P., Schreyer, C., Wildes, J., Yilmaz, Z., Guarda, A. S., Kaplan, A. S., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18101125 · Cited by 211
Aigner, M., Treasure, J., Kaye, W., Kasper, S., & The WFSBP Task Force on Eating Disorders (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.602720 · Cited by 207
The effect of underweight on female and male reproduction
Boutari, C., Pappas, P. D., Mintziori, G., Nigdelis, M. P., Athanasiadis, L., Goulis, D. G., & Mantzoros, C. S. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154229 · Cited by 181
A Placebo-Controlled Pilot Study of Adjunctive Olanzapine for Adolescents with Anorexia Nervosa
Kafantaris, V., Leigh, E., Hertz, S. M., Berest, A., Schebendach, J., Sterling, W. M., Saito, E., Sunday, S. R., Higdon, C., Golden, N. H., et al. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0139 · Cited by 145
Individual psychological therapy in the outpatient treatment of adults with anorexia nervosa
Hay, P., Claudino, A. M., Touyz, S. W., & Elbaky, G. B. A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003909.pub2 · Cited by 145
Validity and utility of subtyping anorexia nervosa
Peat, C. M., Mitchell, J. E., Hoek, H. W., & Wonderlich, S. A. (2009) · International Journal of Eating Disorders · doi:10.1002/eat.20717 · Cited by 140
Clinical psychopharmacology of eating disorders: a research update
Hay, P., & Claudino, A. M. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000460 · Cited by 133
Evidence-based pharmacotherapy of eating disorders
Flament, M. F., Bissada, H., & Spettigue, W. J. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000381 · Cited by 126
Olanzapine versus placebo for out-patients with anorexia nervosa
Attia, E., Kaplan, A. S., Walsh, B. T., Gershkovich, M., Yılmaz, Z., Musante, D. S., & Wang, Y. (2011) · Psychological Medicine · doi:10.1017/s0033291711000390 · Cited by 123
Psychopharmacological advances in eating disorders
Himmerich, H., & Treasure, J. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1383895 · Cited by 119
Hagman, J., Gralla, J., Sigel, E., Ellert, S., Dodge, M., Gardner, R. M., O'Lonergan, T., Frank, G., & Wamboldt, M. Z. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.06.009 · Cited by 118
Lebow, J. R., Sim, L. A., Erwin, P. J., & Murad, M. H. (2012) · International Journal of Eating Disorders · doi:10.1002/eat.22059 · Cited by 117
Atypical antipsychotics and anorexia nervosa: A review
McKnight, R. F., & Park, R. J. (2010) · European Eating Disorders Review · doi:10.1002/erv.988 · Cited by 96
Dold, M., Aigner, M., Klabunde, M., Treasure, J. L., & Kasper, S. F. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000369978 · Cited by 85
Individual psychotherapy in the outpatient treatment of adults with anorexia nervosa
Hay, P. P., Bacaltchuk, J., Byrnes, R. T., Claudino, A. M., Ekmejian, A. A., & Yong, P. Y. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003909 · Cited by 77
Symptoms of psychosis in anorexia and bulimia nervosa
Miotto, P., Pollini, B., Restaneo, A., Favaretto, G., Sisti, D., Rocchi, M., & Preti, A. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2009.03.011 · Cited by 74
Serotonin neurotransmission in anorexia nervosa
Haleem, D. J. (2012) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328357440d · Cited by 73
Medication in AN: A Multidisciplinary Overview of Meta-Analyses and Systematic Reviews
Blanchet, C., Guillaume, S., Bat‐Pitault, F., Carles, M.-É., Clarke, J., Dodin, V., Duriez, P., Gérardin, P., Hanachi, M., Iceta, S., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020278 · Cited by 75
Olanzapine Use for the Adjunctive Treatment of Adolescents with Anorexia Nervosa
Norris, M. L., Spettigue, W. J., Buchholz, A., Henderson, K. A., Gomez, R., Maras, D., Gaboury, I., & Ni, A. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0131 · Cited by 66
Han, R., Bian, Q., & Chen, H. (2022) · Brain and Behavior · doi:10.1002/brb3.2498 · Cited by 63
Eating disorders and psychosis: Seven hypotheses
Seeman, M. V. (2014) · World Journal of Psychiatry · doi:10.5498/wjp.v4.i4.112 · Cited by 62
Dopamine D2/3 receptor antagonism reduces activity-based anorexia
Klenotich, S. J., Ho, E. V., McMurray, M. S., Server, C. H., & Dulawa, S. C. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.109 · Cited by 60
Court, A., Mulder, C., Kerr, M., Yuen, H. P., Boasman, M., Goldstone, S. D., Fleming, J., Weigall, S., Derham, H., Huang, C., et al. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.03.011 · Cited by 60
Pharmacotherapy for Eating Disorders and Obesity
Powers, P. S., & Bruty, H. (2008) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2008.07.009 · Cited by 59
Aripiprazole in anorexia nervosa and low‐weight bulimia nervosa: Case reports
Trunko, M. E., Schwartz, T. A., Duvvuri, V., & Kaye, W. H. (2010) · International Journal of Eating Disorders · doi:10.1002/eat.20807 · Cited by 59
Current and Emerging Directions in the Treatment of Eating Disorders
Brown, T. A., & Keel, P. K. (2012) · Substance Abuse Research and Treatment · doi:10.4137/sart.s7864 · Cited by 58
Psychopharmacologic Treatment of Eating Disorders: Emerging Findings
McElroy, S. L., Guerdjikova, A. I., Mori, N. N., & Keck, P. E. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0573-1 · Cited by 57
Frank, G., & Shott, M. E. (2016) · CNS Drugs · doi:10.1007/s40263-016-0335-6 · Cited by 58
Psychotropic medication use in anorexia nervosa between 1997 and 2009
Fazeli, P. K., Calder, G. L., Miller, K. K., Misra, M., Lawson, E. A., Meenaghan, E. M., Lee, H., Herzog, D. B., & Klibanski, A. (2012) · International Journal of Eating Disorders · doi:10.1002/eat.22037 · Cited by 54
Leggero, C., Masi, G., Brunori, E., Calderoni, S., Carissimo, R., Maestro, S., & Muratori, F. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0072 · Cited by 52
Fornaro, M., Mondin, A. M., Billeci, M., Fusco, A., Prisco, M. D., Caiazza, C., Micanti, F., Calati, R., Carvalho, A. F., & de Bartolomeis, A. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.06.068 · Cited by 60
Favaro, A., Clementi, M., Manara, R., Bosello, R., Forzan, M., Bruson, A., Tenconi, E., Degortes, D., Titton, F., Salle, F. D., et al. (2013) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.120068 · Cited by 52
Self-citationMeta analysis on the efficacy of pharmacotherapy versus placebo on Anorexia Nervosa
de Vos, J., Houtzager, L., Katsaragaki, G., van den Berg, E. M., Cuijpers, P. J., & Dekker, J. (2014) · Journal of Eating Disorders · doi:10.1186/s40337-014-0027-x · Cited by 51
Brewerton, T. D. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0287-6 · Cited by 48
Treatment of Adolescent Eating Disorders: Progress and Challenges.
Lock, J. (2010) · PubMed · Cited by 47
Rodan, S.-C., Bryant, E., Le, A., Maloney, D., Touyz, S. W., McGregor, I. S., Maguire, S., Aouad, P., Barakat, S., Boakes, R. A., et al. (2023) · Journal of Eating Disorders · doi:10.1186/s40337-023-00833-9 · Cited by 46
Atypical Antipsychotics as Augmentation Therapy in Anorexia Nervosa
Marzola, E., Nadia, D., Giovannone, C., Amianto, F., Fassino, S., & Daga, G. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125569 · Cited by 43
Self-citationIs deep brain stimulation a treatment option for anorexia nervosa?
Oudijn, M. S., Storosum, J. G., Nelis, E., & Denys, D. A. J. P. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-277 · Cited by 45
Mehler‐Wex, C., Romanos, M., Kirchheiner, J., & Schulze, U. (2007) · European Eating Disorders Review · doi:10.1002/erv.843 · Cited by 43
Pharmacotherapeutic strategies for the treatment of anorexia nervosa – too much for one drug?
Frank, G. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1748600 · Cited by 43
Balestrieri, M., Oriani, M. G., Simoncini, A., & Bellantuono, C. (2013) · European Eating Disorders Review · doi:10.1002/erv.2240 · Cited by 37
Cassioli, E., Sensi, C., Mannucci, E., Ricca, V., & Rotella, F. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120920453 · Cited by 39
Psychotherapy and Medications for Eating Disorders: Better Together?
Reas, D. L., & Grilo, C. M. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.10.006 · Cited by 37
Spettigue, W. J., Buchholz, A., Henderson, K. A., Feder, S., Moher, D., Kourad, K., Gaboury, I., Norris, M. L., & Ledoux, S. (2008) · BMC Pediatrics · doi:10.1186/1471-2431-8-4 · Cited by 37
Emerging drugs for eating disorder treatment
Steffen, K. J., Roerig, J. L., Mitchell, J. E., & Uppala, S. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.2.315 · Cited by 36
Could Dopamine Agonists Aid in Drug Development for Anorexia Nervosa?
Frank, G. (2014) · Frontiers in Nutrition · doi:10.3389/fnut.2014.00019 · Cited by 37
Current treatment for anorexia nervosa: efficacy, safety, and adherence
Bodell (2010) · Psychology Research and Behavior Management · doi:10.2147/prbm.s13814 · Cited by 35
Thorey, S., Blanchet, C., Guessoum, S. B., Moro, M. R., Ludot, M., & Carretier, É. (2023) · PLoS ONE · doi:10.1371/journal.pone.0278189 · Cited by 35
Psychopharmacological options for adult patients with anorexia nervosa
Miniati, M., Mauri, M., Ciberti, A., Mariani, M. G., Marazziti, D., & Dell’Osso, L. (2015) · CNS Spectrums · doi:10.1017/s1092852914000790 · Cited by 34
Disordered eating attitudes in Egyptian antipsychotic naive patients with schizophrenia
Fawzi, M. H., & Fawzi, M. M. (2011) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2011.04.064 · Cited by 33
Alterations in serotonin transporter and body image-related cognition in anorexia nervosa
Yokokura, M., Terada, T., Bunai, T., Nakaizumi, K., Kato, Y., Yoshikawa, E., Futatsubashi, M., Suzuki, K., Yamasue, H., & Ouchi, Y. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101928 · Cited by 35
Spettigue, W. J., Norris, M. L., Maras, D., Obeid, N., Feder, S., Harrison, M. E., Gomez, R., Fu, M. C., Henderson, K. A., & Buchholz, A. (2018) · Europe PMC (PubMed Central) · Cited by 33
Trastornos de la conducta alimentaria en adolescentes: descripción y manejo
Carolina, L. G., & Janet, T. (2011) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(11)70396-0 · Cited by 58
Recent advances in therapies for eating disorders
Davis, L. E., & Attia, E. (2019) · F1000Research · doi:10.12688/f1000research.19847.1 · Cited by 30
Pharmacotherapy of Eating Disorders
Jackson, C. W., Cates, M., & Lorenz, R. (2010) · Nutrition in Clinical Practice · doi:10.1177/0884533610362239 · Cited by 28
Features of schizophrenia following premorbid eating disorders
Malaspina, D., Walsh‐Messinger, J., Brunner, A., Rahman, N., Corcoran, C. M., Kimhy, D., Goetz, R. R., & Goldman, S. B. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.06.035 · Cited by 28
Psychopharmacology of Eating Disorders in Children and Adolescents
Golden, N. H., & Attia, E. (2011) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2010.11.001 · Cited by 26
Fekete, S., Wewetzer, C., Mehler‐Wex, C., Holtkamp, K., Burger, R., Reichert, S., Taurines, R., Romanos, M., Gerlach, M., & Egberts, K. M. (2017) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000398 · Cited by 21
Facets of shared decision-making on drug treatment for adults with an eating disorder
Himmerich, H., Bentley, J., Lichtblau, N., Brennan, C., & Au, K. (2019) · International Review of Psychiatry · doi:10.1080/09540261.2019.1571995 · Cited by 21
Fitzpatrick, K. K., & Lock, J. (2011) · Europe PMC (PubMed Central) · Cited by 21
The Pharmacological Options in the Treatment of Eating Disorders
Milano, W. D., Rosa, M. D., Milano, L., Riccio, A., Sanseverino, B., & Capasso, A. (2013) · ISRN Pharmacology · doi:10.1155/2013/352865 · Cited by 20
Ketogenic diet and anorexia nervosa
Scolnick, B. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.10.011 · Cited by 19
Yoga as adjunctive therapy in the treatment of people with anorexia nervosa: a Delphi study
Rizzuto, L., Hay, P., Noetel, M., & Touyz, S. W. (2021) · Journal of Eating Disorders · doi:10.1186/s40337-021-00467-9 · Cited by 18
Duggan, H. C., Hardy, G. E., & Waller, G. (2025) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2025.2465745 · Cited by 20
Swenne, I., & Rosling, A. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0098 · Cited by 15
Psychotropic medication use in treatment‐seeking youth with eating disorders
Gorrell, S., Lebow, J. R., Kinasz, K. R., Mitchell, J. E., Goldschmidt, A. B., Grange, D. L., & Accurso, E. C. (2020) · European Eating Disorders Review · doi:10.1002/erv.2788 · Cited by 15
Beykloo, M. Y., Nicholls, D., Simic, M., Brauer, R., Mills, E., & Wong, I. C. K. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031707 · Cited by 14
Giunti, E., Collu, R., Dedoni, S., Castelli, M. P., Fratta, W., Scherma, M., & Fadda, P. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114374 · Cited by 14
Anorexia in human and experimental animal models: physiological aspects related to neuropeptides
Yoshimura, M., Uezono, Y., & Ueta, Y. (2015) · The Journal of Physiological Sciences · doi:10.1007/s12576-015-0386-3 · Cited by 14
Murray, S. B., Quintana, D. S., Loeb, K. L., Griffiths, S., & Grange, D. L. (2018) · Psychological Medicine · doi:10.1017/s0033291718003185 · Cited by 14
Dessain, A., Bentley, J., Treasure, J. L., Schmidt, U. H., & Himmerich, H. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.86083 · Cited by 13
Frank, B., Arnold, S., Jaite, C., & Correll, C. U. (2023) · Journal of Eating Disorders · doi:10.1186/s40337-023-00862-4 · Cited by 13
Tseng, M. M., Chang, C., Liao, S., & Chen, H. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1243-0 · Cited by 12
Tortorella, A., Fabrazzo, M., Monteleone, A., Steardo, L., & Monteleone, P. (2014) · Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" · Cited by 12
Self-citationSaid, O., Filiz, E. S., Stringer, D., Applewhite, B., Kellermann, V., Mutwalli, H., Bektas, S., Akkese, M. N., Kumar, A., Carter, B., et al. (2024) · European Eating Disorders Review · doi:10.1002/erv.3060 · Cited by 12
Pruccoli, J., Pelusi, M., Romagnoli, G., Malaspina, E., Moscano, F. C., & Parmeggiani, A. (2021) · Brain Sciences · doi:10.3390/brainsci11091242 · Cited by 11
A Meta-Analysis of Dropout and Metabolic Effects of Antipsychotics in Anorexia Nervosa
Kan, C., Eid, L., Treasure, J. L., & Himmerich, H. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00208 · Cited by 10
Zeeck, A., Cuntz, U., Herpertz‐Dahlmann, B., Ehrlich, S., Friederich, H., Resmark, G., Hagenah, U., Haas, V. K., Hartmann, A., Greetfeld, M., et al. (2019) · Springer eBooks · doi:10.1007/978-3-662-59606-7_4 · Cited by 10
Milano, W., & Capasso, A. (2019) · The Open Neurology Journal · doi:10.2174/1874205x01913010022 · Cited by 8
Olanzapine for young PEople with aNorexia nervosa (OPEN): results of a feasibility study
Said, O., Stringer, D., Filiz, E. S., Mutwalli, H., Bektas, S., Akkese, M. N., Kellermann, V., Ireland, K., Tyrrell-Bunge, E., Beishon-Murley, D., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06215-y · Cited by 8
Duvvuri, V., Cromley, T., Klabunde, M., Boutelle, K. N., & Kaye, W. H. (2011) · International Journal of Eating Disorders · doi:10.1002/eat.20917 · Cited by 7
Kooij, K. L., Luijendijk, M. C. M., Drost, L., Platenburg, G. J., Elburg, A. A. V., & Adan, R. A. H. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.03.008 · Cited by 7
Evidence-based pharmacotherapy of eating disorders
Flament, M. F., Bissada, H., & Spettigue, W. J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511910395.011 · Cited by 7
Hostetler, C. M., Harkey, S. L., & Bales, K. L. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.02.010 · Cited by 7
Olanzapine treatment in anorexia nervosa: case report.
Dadić-Hero, E., Ružić, K., Pernar, M., Kabalin, M., & Medved, P. (2009) · PubMed · Cited by 7
Pharmacotherapy of Anorexia Nervosa: More Questions than Answers
Hebebrand, J. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.06.016 · Cited by 7
Exploring the link between dopamine dysregulation and eating disorders: A narrative review
Tharwani, Z. H., Shaeen, S. K., Zahid, K., Ahmed, S., Naqrashi, R., Murtaza, A., Mughal, S., Hasanain, M., Anjum, M. U., Eljack, M. M. F., et al. (2025) · Journal of Neuroendocrinology · doi:10.1111/jne.70070 · Cited by 5
Bindseil, I., Stutzman, D. L., Schiel, M. A., Sheffield, K., & Hagman, J. (2025) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2025.0013 · Cited by 5
Recent developments in treatments for eating disorders
Allam, A., & Attia, E. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00773 · Cited by 5
Recent advances in therapies for the eating disorders
Waller, G. (2009) · F1000 Medicine Reports · doi:10.3410/m1-38 · Cited by 5
Donepezil (aricept) as a treatment for anorexia nervosa: a very feasible therapeutic possibility
Bucay, A. H. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902810360 · Cited by 5
Pharmakotherapie der Essstörungen—Ein Update
Bauman, T., & Voderholzer, U. (2025) · Der Nervenarzt · doi:10.1007/s00115-025-01804-y · Cited by 4
Bauman, T., Kolar, D. R., Correll, C. U., Haas, V. K., & Voderholzer, U. (2024) · Pharmacopsychiatry · doi:10.1055/a-2436-9552 · Cited by 4
Metadata
- Authors
- Brambilla, F., Garcia, C. S., Fassino, S., Daga, G. A., Favaro, A., Santonastaso, P., Ramaciotti, C., Bondi, E., Mellado, C., Borriello, R., & Monteleone, P.
- Affiliations
- University of Pisa (IT)
- Venue
- International Clinical Psychopharmacology
- Published
- 2007-07
- Volume
- 22
- Issue
- 4
- Pages
- 197-204
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2045510386
- Cited by
- 156
- References
- 78
- Citations by year
- 2026: 3 · 2025: 14 · 2024: 8 · 2023: 9 · 2022: 2 · 2021: 4 · 2020: 7 · 2019: 10 · 2018: 6 · 2017: 5 · 2016: 1 · 2015: 12 · 2014: 7 · 2013: 9 · 2012: 10
- FWCI
- 10.51
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- International Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Nursing › Nutrition and Dietetics › Nutrition, Health and Food Behavior
- Keywords
- anorexia nervosa, olanzapine, atypical antipsychotics, dopamine antagonists, homovanillic acid, cognitive behavioral therapy, eating disorder symptoms, temperament, aggression, depression, obsessive-compulsive symptoms
- MeSH terms
- Olanzapine, Adult, Anorexia Nervosa, Benzodiazepines, Combined Modality Therapy, Double-Blind Method, Female, Homovanillic Acid, Humans, Antipsychotic Agents, Cognitive Behavioral Therapy, Dopamine Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review